Barostim and the Window of Opportunity in Class II/III HFrEF Patients THT 2024 Discussion

73 views
April 24, 2024

Hear discussion and insights from Drs. J. Thomas Heywood, JoAnn Lindenfeld, Gurusher Panjrath, and Dmitry Yaranov following the THT 2024 symposium.

0 Comments
Login to view comments. Click here to Login